Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ADVB Advanced Biomed Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $6.54 -10.7% | $15.06 -2.0% |
| StockIQ Score | 42D Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 39F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 62C+ | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Advanced Biomed (ADVB) outperforms Ascentage Pharma (AAPG) in technical strength, with a score of 77 versus 18. ADVB also has a stronger overall rating (Moderate vs. Weak) and a higher investor score (52 vs. 37). However, AAPG shows better growth potential with a score of 50 compared to ADVB’s 32. Both share the same valuation score of 38.